Section Arrow
Quote
ARWR.NASDAQ
- Arrowhead Pharmaceuticals
Quotes are at least 15-min delayed:2026/07/01 19:32 EDT
After Hours
Last
 80.44
0 (0.00%)
Bid
79.02
Ask
82
High 81.08 
Low 80.44 
Volume 41.54K 
Regular Hours (Closed)
Last
 80.44
-1.07 (-1.31%)
Day High 
82.385 
Prev. Close
81.51 
1-M High
84.5487 
Volume 
1.98M 
Bid
79.02
Ask
82
Day Low
78.81 
Open
82.28 
1-M Low
69.3 
Market Cap 
11.48B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 80.13 
20-SMA 76.85 
50-SMA 75.97 
52-W High 84.5487 
52-W Low 14.3001 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.27/-3.96
Enterprise Value
11.80B
Balance Sheet
Book Value Per Share
4.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
829.45M
Operating Revenue Per Share
1.82
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CANFCan-Fite Biopharma Ltd4.63+1.66+55.89%-- 
After Hours 4.62 -0.01 -0.22%
ELABPmgc Holdings Inc1.28+0.07+5.79%-- 
After Hours 1.2 -0.08 -6.25%
RXRXRecursion Pharmaceuticals3.67------ 
After Hours 3.6601 -0.0099 -0.27%
LIMNLiminatus Pharma Inc0.1148+0.0044+3.99%-- 
After Hours 0.1449 +0.0301 +26.22%
IOVAIovance Biotherapeutics3.97-0.19-4.57%-- 
After Hours 3.98 +0.01 +0.25%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.